Mirada: RefleXion Announces Licensing Agreement with Mirada Medical to Advance Personalized Cancer Treatment
RefleXion Medical , a therapeutic oncology company pioneering the use of biology-guided radiotherapy ( BgRT )* for all stages of cancer, today announced a non-exclusive, worldwide licensing agreement with Mirada Medical.
Read full article »
Mirada Medical develops an AI-based medical imaging software for cancer treatment.
Read more